Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Steroids for Abnormal Scars
NCT04593706Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
01
Overview
Randomised, single-blind trial of betamethasone sodium phosphate + betamethasone acetate, dexamethasone sodium phosphate, methylprednisolone and triamcinolone acetonide in keloid and Hypertrophic Scar (HS) (2 cohorts), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Patient and Observer Scar Assessment Scale. Status: unknown.
02
Drugs
betamethasone sodium phosphate + betamethasone acetatedexamethasone sodium phosphatemethylprednisolonetriamcinolone acetonide
03
Conditions
keloidHypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT04593706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04593706.